Cargando…
Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms
Coronary microvascular disease (CMVD) is a high risk factor for many cardiovascular events. Due to the limited understanding of its pathophysiological mechanism, modern medicine still lacks therapeutic drugs for CMVD. Existing clinical studies have shown that traditional Chinese medicine (TCM) can e...
Autores principales: | Yang, Zhihua, Liu, Yangxi, Song, Zhihui, Fan, Yujian, Lin, Shanshan, Ge, Zhao, Feng, Shaoling, Liu, Yu, Bi, Yingfei, Wang, Yi, Wang, Xianliang, Mao, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357442/ https://www.ncbi.nlm.nih.gov/pubmed/37484810 http://dx.doi.org/10.7150/ijms.85789 |
Ejemplares similares
-
Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022) -
Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension
por: Yang, Zhihua, et al.
Publicado: (2023) -
Traditional Chinese medicine for heart failure with preserved ejection fraction: clinical evidence and potential mechanisms
por: Fan, Yujian, et al.
Publicado: (2023) -
Efficacy and Safety of Traditional Chinese Medicine Injections for Heart Failure With Reduced Ejection Fraction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Lin, Shanshan, et al.
Publicado: (2021) -
Risk Prediction Models and Novel Prognostic Factors for Heart Failure with Preserved Ejection Fraction: A Systematic and Comprehensive Review
por: Lin, Shanshan, et al.
Publicado: (2023)